Inspira Technologies OXY B.H.N. (NASDAQ:IINN) Cut to Sell at Wall Street Zen

Wall Street Zen cut shares of Inspira Technologies OXY B.H.N. (NASDAQ:IINN) from a hold rating to a sell rating in a report published on Saturday morning.

Separately, Weiss Ratings assumed coverage on shares of Inspira Technologies OXY B.H.N. in a research report on Thursday, October 9th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Inspira Technologies OXY B.H.N. currently has a consensus rating of “Hold” and an average target price of $2.00.

Inspira Technologies OXY B.H.N. Stock Up 2.7%

Shares of NASDAQ IINN opened at $1.13 on Friday. Inspira Technologies OXY B.H.N. has a one year low of $0.40 and a one year high of $1.65. The company has a current ratio of 1.15, a quick ratio of 0.90 and a debt-to-equity ratio of 0.27. The firm’s 50 day simple moving average is $1.21 and its two-hundred day simple moving average is $0.97.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Inspira Technologies OXY B.H.N. stock. Virtu Financial LLC lifted its position in Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) by 254.4% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 47,015 shares of the company’s stock after purchasing an additional 33,749 shares during the period. Virtu Financial LLC owned about 0.37% of Inspira Technologies OXY B.H.N. worth $31,000 as of its most recent SEC filing. Institutional investors and hedge funds own 12.72% of the company’s stock.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.